Aquinox Pharmaceuticals
Why Robinhood?
You can watch AQXP and buy or sell other stocks, ETFs, and their options commission-free!About AQXP
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
AQXP Key Statistics
Stock Snapshot
The current Aquinox Pharmaceuticals(AQXP) stock price is $10.63, with a market capitalization of 322.23M. The stock trades at a price-to-earnings (P/E) ratio of -4.39.
On 2026-04-03, Aquinox Pharmaceuticals(AQXP) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 163.95K.
The stock's 52-week range extends from a low of $6.88 to a high of $37.27.
The stock's 52-week range extends from a low of $6.88 to a high of $37.27.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.